专利号:EP-4186890-A1 优先权日:2021-11-29 标题 :Preparation of n-benzyl-2-(5-bromo-pyridin-2-yl)-acetamide for the synthesis of tirbanibulin 发明人:ARE CELESTE; BALLETTE ROBERTO; DOBARRO RODRÃ?GUEZ ALICIA 权利人:MOEHS IBERICA SL 摘要:The present invention relates to a process for the preparation of N-benzyl-2-(5-bromo-pyridin-2-yl)-acetamide, which is a suitable intermediate for the synthesis of tirbanibulin or a pharmaceutically acceptable salt thereof, as well as to a process for the preparation of tirbanibulin or a pharmaceutically acceptable salt thereof using said N-benzyl-2-(5-bromo-pyridin-2-yl)-acetamide intermediate.
专利号:US-6635767-B2 优先权日:2000-05-23 标 题 :Synthesis of heteroarylamine intermediate compounds 发明人:SONG JINHUA J; YEE NATHAN K; KAPADIA SURESH R 权利人:BOEHRINGER INGELHEIM PHARMA 摘要:Disclosed are novel 2-(5-halopyridyl) and 2-(5-halopyrimidinyl) magnesium halides, processes of making and their use in the efficient synthesis in their respective 5-halo-2-substituted pyridines and pyrimidines.
专利号:US-6822093-B2 优先权日:2000-05-23 标题 :Synthesis of heteroarylamine intermediate compounds 发明人:SONG JINHUA J; YEE NATHAN K 权利人:BOEHRINGER INGELHEIM PHARMA 摘要:Disclosed are novel 2-(5-halopyridyl) and 2-(5-halopyrimidinyl) magnesium halides, processes of making and their use in the efficient synthesis in their respective 5-halo-2-substituted pyridines and pyrimidines.
专利号:US-2003135046-A1 优先权日:2000-05-23 标题 :Synthesis of heteroarylamine intermediate compounds
专利号:US-10125101-B2 优先权日:2016-11-28 标题:Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof 发明人:ECKHARDT MATTHIAS; WAGNER HOLGER; PETERS STEFAN 权利人:BOEHRINGER INGELHEIM INT 摘要:The present invention relates to compounds of general formula I, n nwherein the groups R, R 1 , R 2 , R 3 , m and n are as defined herein, which compounds have valuable pharmacological properties, in particular their ability to bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular type 2 diabetes. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.
专利号:CA-2424916-C 优先权日:2000-05-23 标 题:Novel synthesis of heteroarylamine intermediate compounds